The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Uniting Hepatitis C Patients in Love and Friendship on New Dating Site

Back to News Homepage

Next

Hepatitis C Vaccine Phase I Clinical Trial Kicks Off in Korea

Have Quicker and More Effective Approaches Arrived for Eradicating Hepatitis C?

October 23, 2013

Print this page

Two Hepatitis C drugs the FDA is reviewing have the potential to increase cure rates for the liver virus. Discover more about the experimental medications from Johnson & Johnson and Gilead Sciences, called simeprevir and sofosbuvir.

FDA reviews 2 promising new drugs for hepatitis C

Tuesday, October 22, 2013

By: Associated Press

WASHINGTON — Doctors may soon have two new drug options for patients with hepatitis C, just as the liver-destroying virus becomes a major public health concern for millions of baby boomers.

The Food and Drug Administration holds a public meeting this week to review two experimental medications from Johnson & Johnson and Gilead Sciences. The new drugs, if approved, could offer a quicker, more effective approach to eliminating hepatitis C, a blood-borne disease blamed for 15,000 deaths in the U.S. this year.

Continue reading this entire article:
http://bostonherald.com/business/healthcare/2013/10/fda_reviews_2_promising_new_drugs_for_hepatitis_c

9 Comments
Share
Share

Previous

Uniting Hepatitis C Patients in Love and Friendship on New Dating Site

Back to News Homepage

Next

Hepatitis C Vaccine Phase I Clinical Trial Kicks Off in Korea

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.